Medical Management of Pediatric Community-Acquired Pneumonia
For outpatient children with presumed bacterial pneumonia, amoxicillin 90 mg/kg/day divided into 2 doses is the first-line treatment, while hospitalized fully immunized children should receive ampicillin or penicillin G when local penicillin resistance is low. 1
Outpatient Management
Children Under 5 Years Old
- First-line: Amoxicillin 90 mg/kg/day in 2 doses (maximum 4 g/day) 1
- Alternative: Amoxicillin-clavulanate (amoxicillin component 90 mg/kg/day in 2 doses) 1
- For atypical pneumonia: Azithromycin 10 mg/kg on day 1, then 5 mg/kg/day once daily on days 2-5 1
Children 5 Years and Older
- First-line: Amoxicillin 90 mg/kg/day in 2 doses (maximum 4 g/day) 1
- Add macrolide if atypical pathogens (M. pneumoniae, C. pneumoniae) cannot be clinically distinguished from bacterial CAP 1
- For atypical pneumonia alone: Azithromycin (10 mg/kg day 1, then 5 mg/kg days 2-5; max 500 mg/250 mg) 1
- Alternative for children >7 years: Doxycycline 2-4 mg/kg/day in 2 doses 1
Inpatient Management
Fully Immunized Children (Low Local Penicillin Resistance)
- Preferred: Ampicillin 150-200 mg/kg/day every 6 hours OR Penicillin G 200,000-250,000 U/kg/day every 4-6 hours 1
- Alternatives: Ceftriaxone 50-100 mg/kg/day every 12-24 hours OR Cefotaxime 150 mg/kg/day every 8 hours 1
- This is a strong recommendation based on moderate-quality evidence 1
Not Fully Immunized OR High Local Penicillin Resistance OR Life-Threatening Infection
- Preferred: Ceftriaxone 50-100 mg/kg/day every 12-24 hours OR Cefotaxime 150 mg/kg/day every 8 hours 1
- Third-generation cephalosporins remain effective despite current resistance patterns in North America 1
- Vancomycin has not proven superior to third-generation cephalosporins for pneumococcal pneumonia 1
When Atypical Pathogens Are Suspected
Add macrolide therapy to β-lactam antibiotics for hospitalized children when M. pneumoniae or C. pneumoniae are considerations 1
- Preferred: IV azithromycin 10 mg/kg on days 1-2, then transition to oral 1
- Alternatives: IV erythromycin lactobionate 20 mg/kg/day every 6 hours 1
Suspected Community-Associated MRSA
Add vancomycin or clindamycin (based on local susceptibility) to β-lactam therapy 1
- Vancomycin: 40-60 mg/kg/day every 6-8 hours (or dose to achieve AUC/MIC >400) 1
- Clindamycin: 40 mg/kg/day every 6-8 hours (if susceptible) 1
Pathogen-Specific Dosing for Resistant Organisms
Highly Resistant S. pneumoniae (MIC ≥4.0 μg/mL)
- Parenteral preferred: Ceftriaxone 100 mg/kg/day every 12-24 hours 1
- Oral preferred: Levofloxacin (age-based dosing) OR Linezolid (30 mg/kg/day in 3 doses for <12 years; 20 mg/kg/day in 2 doses for ≥12 years) 1
MRSA Resistant to Clindamycin
- Parenteral: Vancomycin 40-60 mg/kg/day every 6-8 hours OR Linezolid 1
- Oral: May require entire treatment course with parenteral therapy 1
Treatment Duration
Recent evidence suggests shorter courses may be adequate. The 2025 ATS guidelines recommend minimum 3 days for outpatients and nonsevere hospitalized CAP who reach clinical stability, rather than the traditional ≥5 days 2. However, the optimal duration for pediatric bacterial pneumonia remains debated 3, and the 2011 PIDS/IDSA guidelines (the primary pediatric-specific guideline) do not specify exact duration.
Critical Pitfalls to Avoid
- Do not withhold antibiotics in hospitalized children or those with comorbidities, even with positive viral testing 2
- Do not use vancomycin as first-line for pneumococcal pneumonia—third-generation cephalosporins are equally effective 1
- Consider local resistance patterns when choosing between ampicillin/penicillin versus cephalosporins 1
- Add MRSA coverage only when clinically suspected (severe illness, empyema, necrotizing features) 1
- Verify immunization status—this fundamentally changes antibiotic selection 1